F/M Investments’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.98M Sell
40,086
-25,453
-39% -$3.32M 0.26% 76
2025
Q4
$7.97M Buy
65,539
+8,627
+15% +$1.08M 0.3% 78
2025
Q3
$6.39M Buy
56,912
+3,584
+7% +$420K 0.25% 93
2025
Q2
$7.15M Buy
53,328
+1,461
+3% +$160K 0.26% 78
2025
Q1
$3.49M Buy
51,867
+979
+2% +$67.3K 0.14% 160
2024
Q4
$3.17M Sell
50,888
-21,574
-30% -$2.01M 0.12% 164
2024
Q3
$11.4M Sell
72,462
-283
-0.4% -$43.6K 0.36% 87
2024
Q2
$11M Buy
+72,745
New +$8.73M 0.4% 77

Other funds holding TMDX

F/M Investments's TMDX Position: Q1 2026 in Review

F/M Investments reduced its Transmedics (TMDX) stake by 39% in Q1 2026, selling an estimated $3.32M and leaving 40,086 shares worth $3.98M. The position accounts for 0.26% of the portfolio, ranked #76.

F/M Investments first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $11.4M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • F/M Investments held 40,086 shares of Transmedics worth $3.98M as of Q1 2026.
  • F/M Investments sold 25,453 Transmedics shares in Q1 2026, an estimated $3.32M.
  • Transmedics made up 0.26% of F/M Investments's portfolio in Q1 2026, its #76 holding.
  • F/M Investments first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
  • F/M Investments's Transmedics position peaked at $11.4M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.